日本語
 
Help Privacy Policy ポリシー/免責事項
  詳細検索ブラウズ

アイテム詳細


公開

学術論文

Reconstructing the in vivo dynamics of 1 hematopoietic stem cells from telomere 2 length distributions

MPS-Authors
/persons/resource/persons56995

Werner,  Benjamin
Department Evolutionary Theory, Max Planck Institute for Evolutionary Biology, Max Planck Society;

/persons/resource/persons56973

Traulsen,  Arne
Department Evolutionary Theory, Max Planck Institute for Evolutionary Biology, Max Planck Society;

Fulltext (restricted access)
There are currently no full texts shared for your IP range.
フルテキスト (公開)

Werner_et_al_2015.pdf
(プレプリント), 2MB

付随資料 (公開)
There is no public supplementary material available
引用

Werner, B., Beier, F., Hummel, S., Balabanov, S., Lassay, L., Orlikowsky, T., Dingli, D., Brümmendorf, T. H., & Traulsen, A. (2015). Reconstructing the in vivo dynamics of 1 hematopoietic stem cells from telomere 2 length distributions. eLife, 4:. doi:10.7554/eLife.08687.


引用: https://hdl.handle.net/11858/00-001M-0000-0029-010B-C
要旨
We investigate the in vivo patterns of stem cell divisions in the human hematopoietic system throughout life. In particular, we analyze the shape of telomere length distributions underlying stem cell behavior within individuals. Our mathematical model shows that these distributions contain a fingerprint of the progressive telomere loss and the fraction of symmetric cell proliferations. Our predictions are tested against measured telomere length distributions in humans across all ages, collected from lymphocyte and granulocyte sorted telomere length data of 356 healthy individuals, including 47 cord blood and 28 bone marrow samples. We find an increasing stem cell pool during childhood and adolescence and an approximately maintained stem cell population in adults. Furthermore, our method is able to detect individual differences from a single tissue sample, i.e. a single snapshot. Prospectively, this allows us to compare cell proliferation between individuals and identify abnormal stem cell dynamics, which affects the risk of stem cell related diseases.